PyInvesting

Market research

TE1.F Bio-Techne Corporation

F EUR Healthcare

Latest close

67.00 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
10B
P/E ratio
70.41
Analyst target
549.6
Dividend yield
0.4%
Beta
1.27

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Bio-Techne Corporation is currently in a long term uptrend where the price is trading 29.0% above its 200 day moving average.

From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 19.3.

Bio-Techne Corporation's total revenue rose by 21.3% to $224M since the same quarter in the previous year.

Its net income has dropped by 61.3% to $46M since the same quarter in the previous year.

Finally, its free cash flow grew by 39.3% to $78M since the same quarter in the previous year.

Based on the above factors, Bio-Techne Corporation gets an overall score of 4/5.